Discovery & Development: Partnering with Patient-Led Research Networks
An increasing number of patient groups are investing in drug, diagnostic and device discovery and development. Known as patient-led research networks, these independent, non-profit organizations are found around the world.
Business development and licensing executives at a diverse range of companies gain concrete advantages by building partnerships with patient-led research networks through identification and commercialization of promising compounds.
Recently, MK&A’s Mark Krueger, MPH, president, and Veronica Lopez, MPH, strategic associate, co-authored an article with Yvonne Schlaeppi, JD, independent non-executive director of Stallergenes Greer, which explores this topic in the Business Development and Licensing Journal.
Back to Full Blog List